Skip to main content

Market Overview

Benzinga's Top Downgrades


Analysts at JP Morgan downgraded ViroPharma (NASDAQ: VPHM) from “overweight” to “neutral.” The target price for ViroPharma has been raised from $45 to $50. ViroPharma's shares closed at $49.42 yesterday.

Analysts at Canaccord Genuity downgraded Hologic (NASDAQ: HOLX) from “buy” to “hold.” The target price for Hologic has been lowered to $19. Hologic's shares closed at $22.90 yesterday.

Analysts at Macquarie downgraded Symantec (NASDAQ: SYMC) from “outperform” to “neutral.” The target price for Symantec has been lowered to $24. Symantec's shares closed at $23.21 yesterday.

UBS downgraded Gogo (NASDAQ: GOGO) from “buy” to “neutral.” Gogo's shares closed at $24.15 yesterday.

Latest Ratings for VPHM

Nov 2013Stifel NicolausDowngradesBuyHold
Nov 2013JP MorganDowngradesOverweightNeutral
Nov 2013PiperJaffrayDowngradesOverweightNeutral

View More Analyst Ratings for VPHM
View the Latest Analyst Ratings


Related Articles (HOLX + VPHM)

View Comments and Join the Discussion!

Posted-In: Top DowngradesDowngrades Analyst Ratings

Latest Ratings

DHRWells FargoMaintains280.0
TALMorgan StanleyMaintains75.0
HCARBC CapitalMaintains232.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at